Results 111 to 120 of about 1,586 (183)

Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications. [PDF]

NPJ Breast Cancer
Griguolo G, Bottosso M, Paré L, Miglietta F, Generali DG, Musolino A, Spazzapan S, Vernaci GM, Giarratano T, Cappellesso R, Bicciato S, Piacentini F, Tagliafico E, Cagossi K, Tosi A, Schiavi F, Prat A, Dieci MV, Guarneri V.   +18 more
europepmc   +1 more source

Interplay between HER2-Low status, hormone receptor expression, and therapeutic response to cyclin-dependent kinase 4/6 inhibitors as first-line treatment in luminal-like metastatic breast cancer: The CYCLHER study. [PDF]

Breast
Pontolillo L, Munzone E, Vigneri P, Pistelli M, Palazzo A, La Verde N, Mazzotta M, Paris I, Alesini D, Santini D, Cannita K, Orlandi A, Magnolfi E, Giacinti L, Raffaele M, Carbognin L, Santoro A, Rossi A, Arcuri G, Sangalli C, Garrone O, Mulè A, Valenza C, Berardi R, Tortora G, Bria E, Curigliano G, Giannarelli D, Fabi A.   +28 more
europepmc   +1 more source

Day 4 Versus Day 5 Fresh Embryo Transfer in In Vitro Fertilization: Is It All About Timing? [PDF]

J Clin Med
Şişmanoğlu A, Oğlak SC, Özcan C, Uluğ U.   +3 more
europepmc   +1 more source

[Sex and gender differences in posttraumatic stress disorder: current evidence on etiology, trajectory and treatment]. [PDF]

Nervenarzt
Haering S, Meyer C, Knaevelsrud C, Engel S.   +3 more
europepmc   +1 more source

[Adrenocortical carcinoma (ACC): current surgical treatment strategies]. [PDF]

Chirurgie (Heidelb)
Bartsch DK.
europepmc   +1 more source

HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations. [PDF]

Int J Mol Sci
Falcone I, Giontella E, Giuliani S, Borghesani G, Valenti A, Zambonin V, Monteverdi S, Carbognin L, Bria E, Ciuffreda L, Conciatori F, Bazzichetto C, Pedron S, Nottegar A, Zanelli S, Muzzarelli A, Fabi A, Migliaccio S, Ferretti E, Bei R, Fiorio E, Fanciulli M, Sperduti I, Caliò A, Milella M.   +24 more
europepmc   +1 more source

Does FDG PETCT have a predictive value for neoadjuvant chemotherapy response in nonmetastatic breast cancer? [PDF]

Ir J Med Sci
Dogan E, Disli SY, Asik E, Karacavus S, Ozdemir F.   +4 more
europepmc   +1 more source

Feasibility and efficacy of random-start progestin-primed ovarian stimulation: a multicenter pilot randomized controlled trial in oocyte donation. [PDF]

Reprod Biol Endocrinol
Mathieu d'Argent E, Guivarc'h-Leveque A, Catteau-Jonard S, Cedrin-Durnerin I, Peigné M, Jung C, Goro S, Wang XX, Massin N.   +8 more
europepmc   +1 more source

The Effectiveness and Adverse Events of Eribulin Monotherapy in Indonesian Metastatic Breast Cancer (MBC) Patients. [PDF]

Asian Pac J Cancer Prev
Adiputra PAT, Siswiandari KM, Hangesti D, Qodir N, Gautama W, Hermansyah D.   +5 more
europepmc   +1 more source